These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4599855)

  • 21. [Relationship between the structure and function of polysynthetic penicillins].
    Naĭler Dzh
    Antibiotiki; 1971 Oct; 16(10):877-82. PubMed ID: 5003055
    [No Abstract]   [Full Text] [Related]  

  • 22. [Phosphatase from Proteus mirabilis].
    Salikhova ZZ; Sokolova RB; Iusupova DV
    Prikl Biokhim Mikrobiol; 2001; 37(2):170-4. PubMed ID: 11357420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of beta-lactamase location in Escherichia coli on penicillin synergy.
    Neu HC
    Appl Microbiol; 1969 Jun; 17(6):783-6. PubMed ID: 4894721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An extracellular penicillinase controlled by an R factor].
    Romero E; Perduca M
    G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):204-10. PubMed ID: 4605499
    [No Abstract]   [Full Text] [Related]  

  • 25. Trimodal response of Escherichia coli and Proteus mirabilis to penicillins.
    Greenwood D; O'Grady F
    Nature; 1970 Oct; 228(5270):457-8. PubMed ID: 4921466
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of penicillinase-resistant penicillins to increase the susceptibility of gram-negative bacteria to antibiotics.
    Farrar WE; O'Dell NM; Krause JM
    Ann Intern Med; 1967 Oct; 67(4):733-43. PubMed ID: 4862467
    [No Abstract]   [Full Text] [Related]  

  • 27. The purification and properties of penicillin beta-lactamases mediated by transmissible R factors in Escherichia coli.
    Yamagishi S; O'Hara K; Sawai T; Mitsuhashi S
    J Biochem; 1969 Jul; 66(1):11-20. PubMed ID: 4980693
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro and in vivo antibacterial activity of cephapirin (author's transl)].
    Mitsuhashi S; Yaginuma S; Ono H; Kurashige S
    Jpn J Antibiot; 1974 Apr; 27(2):152-6. PubMed ID: 4211466
    [No Abstract]   [Full Text] [Related]  

  • 29. [A comparative analysis of beta-lactamase activity in enterobacteria].
    Demikhovskaia AA; Lukach IG; Zaritskiĭ AM; Kotov AI
    Mikrobiol Zh (1978); 1984; 46(2):36-9. PubMed ID: 6401094
    [No Abstract]   [Full Text] [Related]  

  • 30. Investigation of the protease forming ability of Serratia marcescens and one of its mutant strains.
    Ovenfors C; Marklund M; Johnsson E; Lundblad G
    Acta Chem Scand; 1973 Oct; 27(10):3791-800. PubMed ID: 4205979
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of osmolality on the response of Escherichia coli and Proteus mirabilis to penicillins.
    Greenwood D; O'Grady F
    Br J Exp Pathol; 1972 Oct; 53(5):457-64. PubMed ID: 4563453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study of in vitro activity of 3 cephalosporins and their combination with 2 beta-lactamase inhibitors against 4 enterobacteria strains producing extended spectrum beta-lactamase].
    Cattoen C; Duflos D; Bouillet L; Chatelain C; Mazars E
    Pathol Biol (Paris); 1997 May; 45(5):425-9. PubMed ID: 9296097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 beta-lactamase produced by Proteus mirabilis strains.
    Bret L; Chanal C; Sirot D; Labia R; Sirot J
    J Antimicrob Chemother; 1996 Aug; 38(2):183-91. PubMed ID: 8877532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the -lactamase specified by the resistance factor R-1818 in E. coli K12 and other Gram-negative bacteria.
    Dale JW
    Biochem J; 1971 Jul; 123(4):501-5. PubMed ID: 4942447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitor-resistant beta-lactamases.
    Nicolas-Chanoine MH
    J Antimicrob Chemother; 1997 Jul; 40(1):1-3. PubMed ID: 9249197
    [No Abstract]   [Full Text] [Related]  

  • 36. R-factor-mediated resistance to tetracycline in Proteus mirabilis.
    Franklin TJ; Rownd R
    J Bacteriol; 1973 Jul; 115(1):235-42. PubMed ID: 4268690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency of beta-lactam susceptibility in CTX-M-type extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis according to the new CLSI recommendations.
    de Oliveira KR; de Freitas AL; Willers DM; Barth AL; Zavascki AP
    J Antimicrob Chemother; 2010 Nov; 65(11):2481-3. PubMed ID: 20846935
    [No Abstract]   [Full Text] [Related]  

  • 38. Polymyxin B-penicillin antagonism in Proteus mirabilis.
    Sud IJ; Feingold DS
    Antimicrob Agents Chemother; 1978 Dec; 14(6):916-8. PubMed ID: 217303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance of enteropathogenic strains of Escherichia coli to penicillins and cephalosporins.
    Garber N; Frimerman H
    Isr J Med Sci; 1973 Jul; 9(7):888-94. PubMed ID: 4126067
    [No Abstract]   [Full Text] [Related]  

  • 40. R factor-mediated and chromosomal resistance to ampicillin in Escherichia coli.
    Roupas A; Pitton JS
    Antimicrob Agents Chemother; 1974 Feb; 5(2):186-91. PubMed ID: 4599117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.